Zimmer Biomet Holdings Inc (NYSE:ZBH), a global leader in musculoskeletal healthcare, has reported an insider sell according to a recent SEC filing. Group President, Asia Pacific Sang Yi has sold 1,705 shares of the company on March 7, 2024. The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Zimmer Biomet Holdings Inc specializes in designing, manufacturing, and marketing orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
According to the filing, the insider has made significant changes to their holdings in the company over the past year. Sang Yi has sold a total of 1,705 shares and has not made any purchases of the company's stock during this period.
The insider transaction history for Zimmer Biomet Holdings Inc shows a pattern of insider activity. Over the past year, there have been 7 insider buys and 3 insider sells. This activity provides a glimpse into the sentiment insiders have about the company's stock performance and future outlook.
On the valuation front, Zimmer Biomet Holdings Inc's shares were trading at $126.86 on the day of the insider's recent transaction. The company has a market cap of $25.992 billion. The price-earnings ratio stands at 25.92, which is lower than the industry median of 27.17 and also below the company's historical median price-earnings ratio.
The stock's price-to-GF-Value ratio is currently at 0.93, with a GF Value of $136.48, indicating that Zimmer Biomet Holdings Inc is Fairly Valued based on its GF Value. The GF Value is a proprietary intrinsic value estimate from GuruFocus, which takes into account historical trading multiples, a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
Investors and analysts often monitor insider sell transactions to gain insights into a company's internal perspective. While a single transaction may not be indicative of a trend, the collective pattern of buys and sells can provide additional context to the company's financial health and future prospects.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
